Literature DB >> 9163277

[Recovery and psychomimetic reactions following S-(+)-ketamine].

W Engelhardt1.   

Abstract

Ketamine is a racemic mixture containing equal parts of S-(+)-ketamine and R-(-)-ketamine. Their potency relation is approximately 4:1. In early human studies S-(+)-ketamine was presumed to produce the desired anaesthetic effects and R-(-)-ketamine the undesired psychic emergence reactions. Therefore, ketamine was compared in a number of randomised studies in volunteers and patients with racemic ketamine. This review addresses the impact of S-(+)-ketamine on recovery from anaesthesia, incidence and content of vivid dreams, and other side effects. The dose relation applied in the studies was 1:2. With only one exception, the recovery phase was clearly shorter after S-(+)-ketamine compared to racemic ketamine irrespective of its application as a single bolus, a bolus followed by continuous infusion, or an intramuscular injection. However, the incidence of psychic emergence reactions was lower after S-(+)-ketamine in only a single study. In conclusion, S-(+)-ketamine should be always combined with a hypnotic or sedative drug in clinical anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163277     DOI: 10.1007/pl00002463

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  9 in total

1.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

2.  Intranasal sufentanil/midazolam versus ketamine/midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison.

Authors:  J A Roelofse; E A Shipton; C J de la Harpe; R J Blignaut
Journal:  Anesth Prog       Date:  2004

3.  Comparison of analgesic/sedative effect of racemic ketamine and S(+)-ketamine during cardiac catheterization in newborns and children.

Authors:  C Pees; N A Haas; P Ewert; F Berger; P E Lange
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

4.  The analgesic effect of combined treatment with intranasal S-ketamine and intranasal midazolam compared with morphine patient-controlled analgesia in spinal surgery patients: a pilot study.

Authors:  Christine Riediger; Manuel Haschke; Christoph Bitter; Thomas Fabbro; Stefan Schaeren; Albert Urwyler; Wilhelm Ruppen
Journal:  J Pain Res       Date:  2015-02-13       Impact factor: 3.133

5.  Clinical and pharmacokinetic evaluation of S-ketamine for intravenous general anaesthesia in horses undergoing field castration.

Authors:  Daniela Casoni; Claudia Spadavecchia; Beat Wampfler; Wolfgang Thormann; Olivier L Levionnois
Journal:  Acta Vet Scand       Date:  2015-05-03       Impact factor: 1.695

Review 6.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

7.  A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial.

Authors:  Xinlei Lu; Ling Tang; Haiyan Lan; Chunli Li; Han Lin
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 8.  Advantages of ketamine in pediatric anesthesia.

Authors:  Alessandro Simonini; Etrusca Brogi; Marco Cascella; Alessandro Vittori
Journal:  Open Med (Wars)       Date:  2022-07-06

9.  Prehospital analgesia using nasal administration of S-ketamine--a case series.

Authors:  Joakim Johansson; Jonas Sjöberg; Marie Nordgren; Erik Sandström; Folke Sjöberg; Henrik Zetterström
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-05-14       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.